Skip to content
rdmorin edited this page Jan 11, 2025 · 35 revisions

bibliography: 'morinlab.bib' csl: 'NLM.csl' link-citations: true nocite: | @richterRecurrentMutationID32012, @spinaGeneticsNodalMarginal2016, @schmitzBurkittLymphomaPathogenesis2012

[[TOC]]

Overview

ID3 was first reported as mutated in BL in 2012 by Richter et al.[@richterRecurrentMutationID32012] The existence of mutations in DLBCL were described in 2012 by Schmitz et al[@schmitzBurkittLymphomaPathogenesis2012] and later in MZL by Spina et al.[@spinaGeneticsNodalMarginal2016]

Relevance tier by entity

include:tables/table1_ID3

Mutation incidence in large patient cohorts (GAMBL reanalysis)

DLBCL

include:tables/DLBCL_ID3.md

BL

include:tables/BL_ID3.md

Mutation pattern and selective pressure estimates

include:tables/dnds_ID3.md

aSHM regions

chr_name hg19_start hg19_end region regulatory_comment
chr1 23885584 23885835 TSS NA

include:tables/browser_ID3.md

Expression

include:tables/mermaid_ID3.md

References

Disclaimer

The content in these pages has been populated, in part, by an automated process. Although we have scrutinized every page to ensure accuracy, errors will inevitably exist. If you find an error please report it as an issue and we will address it.

In particular, let us know if you feel that an important citation is missing or if a paper has been cited incorrectly.

License

This work is licensed under a Creative Commons Attribution 4.0 International License.

You are free to:

Share — copy and redistribute the material in any medium or format for any purpose, even commercially.

Adapt — remix, transform, and build upon the material for any purpose, even commercially. The licensor cannot revoke these freedoms as long as you follow the license terms.

Clone this wiki locally